Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Buy
+542,415
New +$12M 0.01% 1502
2025
Q1
Sell
-38,261
Closed -$912K 4682
2024
Q4
$912K Sell
38,261
-27,864
-42% -$778K ﹤0.01% 3258
2024
Q3
$1.85M Sell
66,125
-29,572
-31% -$835K ﹤0.01% 2761
2024
Q2
$2.5M Sell
95,697
-11,220
-10% -$233K ﹤0.01% 2459
2024
Q1
$2.34M Sell
106,917
-21,689
-17% -$465K ﹤0.01% 2509
2023
Q4
$2.99M Buy
128,606
+110,906
+627% +$2.23M ﹤0.01% 2339
2023
Q3
$349K Buy
+17,700
New +$349K ﹤0.01% 3556

Other funds holding RXO

David Shaw's RXO Position: Q2 2026 in Review

David Shaw opened a new position in RXO (RXO) in Q2 2026: 542,415 shares worth $15M. The stake represents 0.01% of the portfolio and ranks #1502 among its holdings. This is a return to the name: David Shaw previously reported a position in RXO as recently as Q4 2024.

David Shaw first reported a position in RXO in Q3 2023 and has held it in 7 quarters since. 302 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • David Shaw held 542,415 shares of RXO worth $15M as of Q2 2026.
  • RXO was a new David Shaw position in Q2 2026.
  • RXO made up 0.01% of David Shaw's portfolio in Q2 2026, its #1502 holding.
  • David Shaw first reported a position in RXO in Q3 2023 and has held it in 7 quarters since.
  • 302 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.